cp wire

CP Wire Articles

  • Allogene completed a $300 Million Series A round in April of 2018
  • Investors in the Series A round included Gilead and Pfizer

Allogene Therapeutics, Inc., a clinical-... read more

Thu, 09/6/18 - 09:37 am
  • VX-659 and VX-445 are next gen correctors
  • Correctors fix the defective CFTR protein so that it can move to the proper place on the cell surface
  • Vertex expects to submit an... read more
Thu, 09/6/18 - 09:20 am

Historical patent and exclusivity data for FDA-approved drugs now available

Hillsborough, New Jersey – September 5, 2018 – Bruce Pokras’ ... read more

Wed, 09/5/18 - 01:34 pm
  • Lenvima is the first new systemic therapy approved for the first-line treatment of unresectable HCC in China in ten years
  • In China, there are approximately 395,000 new cases of liver... read more
Wed, 09/5/18 - 09:24 am

EpicGenetics announced on9/5/18 that the U.S. Food and Drug Administration (FDA) has given approval to the Massachusetts General Hospital for a human clinical trial of BCG (an inexpensive generic... read more

Wed, 09/5/18 - 09:08 am

Seres Therapeutics, Inc. (Nasdaq:MCRB) today announced the appointment of Meryl Zausner, a seasoned biopharmaceutical executive, to its Board of Directors. Ms. Zausner brings decades of financial... read more

Tue, 09/4/18 - 10:02 am

LEO Pharma and Bayer announced today the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States.... read more

Tue, 09/4/18 - 09:55 am

  • Many pathogens may inhibit or modulate their host’s immune system and thus circumvent immune defense
  • Immune system activating therapies may open transformative opportunities... read more
Tue, 09/4/18 - 09:44 am

Macrolide Pharmaceuticals announced on 9/4/18 a leadership expansion that adds significant expertise in drug development, clinical strategy, finance and... read more

Tue, 09/4/18 - 09:28 am

Sunovion Pharmaceuticals Inc. (Sunovion) announced on 8/31/18 that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application (NDA) for... read more

Fri, 08/31/18 - 10:42 am

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental Biologics License Application (sBLA) for Sprycel (dasatinib... read more

Thu, 08/30/18 - 09:44 am
CP Staff
  • Domagrozumab Ph II study did not meet primary endpoint
  • Pfizer is also developing a gene therapy, PF-06939926, for DMD
  • PF-06939926 has orphan status in the US and Europe... read more
Thu, 08/30/18 - 09:31 am
CP Staff
  • Onvansertib also has orphan status in the US
  • Onvansertib has the potential to improve clinical efficacy in Acute Myeloid Leukemia (AML), metastatic Castration-Resistant Prostate... read more
Wed, 08/29/18 - 12:24 pm
CP Staff
  • ATB-346 is a hydrogen sulfide-releasing derivative of naproxen
  • H2s has been shown to play important role in the maintenance of gastric mucosal integrity.

... read more

Wed, 08/29/18 - 09:57 am
CP Staff
  • OMS721 is also being studied in atypical hemolytic uremic syndrome, IgA nephropathy, and lupus nephritis
  • The drug also has orphan status for the treatment of primary IgA nephropathy... read more
Tue, 08/28/18 - 11:53 am
CP Staff

Reflection Biotechnologies Limited ("ReflectionBio") announced on 8/28/18 that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ReflectionBio's RBIO-101... read more

Tue, 08/28/18 - 09:20 am
CP Staff
  • The primary objective of the study is to determine whether the combination of prexigebersen and LDAC provides greater efficacy than would be expected with LDAC alone... read more

Mon, 08/27/18 - 09:49 am
CP Staff

Magnolia Neurosciences Corporation (Magnolia) announced on 8/27/18 that Korysso Therapeutics, Inc. (DBA: Magnolia Tejas Corporation), the company’s wholly owned, Houston-based subsidiary, has... read more

Mon, 08/27/18 - 09:22 am
CP Staff

LifeMax Laboratories, Inc. (“LifeMax”) announced on 8/27/18 an exclusive worldwide license from Novartis Pharma AG for the right to develop, manufacture and commercialize BPR277, a clinical stage... read more

Mon, 08/27/18 - 09:12 am
CP Staff


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.